TW201829017A - 於消化道之吸收降低的改善用組成物、及於消化道之吸收的促進用組成物 - Google Patents
於消化道之吸收降低的改善用組成物、及於消化道之吸收的促進用組成物 Download PDFInfo
- Publication number
- TW201829017A TW201829017A TW106136624A TW106136624A TW201829017A TW 201829017 A TW201829017 A TW 201829017A TW 106136624 A TW106136624 A TW 106136624A TW 106136624 A TW106136624 A TW 106136624A TW 201829017 A TW201829017 A TW 201829017A
- Authority
- TW
- Taiwan
- Prior art keywords
- absorption
- composition
- digestive tract
- cystine
- present
- Prior art date
Links
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 155
- 210000001035 gastrointestinal tract Anatomy 0.000 title claims abstract description 123
- 239000000203 mixture Substances 0.000 title claims abstract description 116
- 230000001737 promoting effect Effects 0.000 title claims abstract description 20
- 230000003247 decreasing effect Effects 0.000 title abstract description 7
- 229960003067 cystine Drugs 0.000 claims abstract description 75
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims abstract 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 65
- 235000015097 nutrients Nutrition 0.000 claims description 56
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 235000013305 food Nutrition 0.000 claims description 30
- 108090000623 proteins and genes Proteins 0.000 claims description 25
- 235000001014 amino acid Nutrition 0.000 claims description 21
- 150000001413 amino acids Chemical class 0.000 claims description 17
- 229940088594 vitamin Drugs 0.000 claims description 16
- 229930003231 vitamin Natural products 0.000 claims description 16
- 235000013343 vitamin Nutrition 0.000 claims description 16
- 239000011782 vitamin Substances 0.000 claims description 16
- 150000002632 lipids Chemical class 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 11
- 235000010755 mineral Nutrition 0.000 claims description 11
- 239000011707 mineral Substances 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 8
- 235000000346 sugar Nutrition 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- 229930003316 Vitamin D Natural products 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- 235000019166 vitamin D Nutrition 0.000 claims description 7
- 239000011710 vitamin D Substances 0.000 claims description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 229940046008 vitamin d Drugs 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229930003270 Vitamin B Chemical group 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 239000011720 vitamin B Chemical group 0.000 claims description 5
- 235000019156 vitamin B Nutrition 0.000 claims description 5
- 150000008163 sugars Chemical class 0.000 claims description 4
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 71
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 51
- 239000008103 glucose Substances 0.000 description 51
- 235000002639 sodium chloride Nutrition 0.000 description 35
- 150000003839 salts Chemical class 0.000 description 34
- 238000000034 method Methods 0.000 description 33
- 230000009467 reduction Effects 0.000 description 26
- 230000000694 effects Effects 0.000 description 24
- 230000014509 gene expression Effects 0.000 description 23
- -1 heterocyclic amines Chemical class 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 229940024606 amino acid Drugs 0.000 description 19
- 206010025476 Malabsorption Diseases 0.000 description 16
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 16
- 230000037406 food intake Effects 0.000 description 14
- 230000000968 intestinal effect Effects 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 230000007423 decrease Effects 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 210000000813 small intestine Anatomy 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000002354 daily effect Effects 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 108010063290 Aquaporins Proteins 0.000 description 8
- 108010039206 Biotinidase Proteins 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 102100026044 Biotinidase Human genes 0.000 description 7
- 108091052347 Glucose transporter family Proteins 0.000 description 7
- 239000005018 casein Substances 0.000 description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical group NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 7
- 235000021240 caseins Nutrition 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 102000010637 Aquaporins Human genes 0.000 description 6
- 108091006783 Folate transporters Proteins 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 108091006272 SLC5A6 Proteins 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 108050005273 Amino acid transporters Proteins 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 102000037909 Folate transporters Human genes 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 102100027046 Sodium-dependent multivitamin transporter Human genes 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 235000019152 folic acid Nutrition 0.000 description 5
- 239000011724 folic acid Substances 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 108010082406 peptide permease Proteins 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 108010078070 scavenger receptors Proteins 0.000 description 5
- 102000014452 scavenger receptors Human genes 0.000 description 5
- 102100024016 G patch domain and ankyrin repeat-containing protein 1 Human genes 0.000 description 4
- 101000904261 Homo sapiens G patch domain and ankyrin repeat-containing protein 1 Proteins 0.000 description 4
- 101000760646 Homo sapiens Phosphatidylserine lipase ABHD16A Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000009207 exercise therapy Methods 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 235000003642 hunger Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 102000034263 Amino acid transporters Human genes 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 108010078791 Carrier Proteins Proteins 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- 102000042092 Glucose transporter family Human genes 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 239000007937 lozenge Substances 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- 235000019161 pantothenic acid Nutrition 0.000 description 3
- 239000011713 pantothenic acid Substances 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 210000001187 pylorus Anatomy 0.000 description 3
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 101150076489 B gene Proteins 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 208000005232 Glossitis Diseases 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 208000001140 Night Blindness Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010037549 Purpura Diseases 0.000 description 2
- 241001672981 Purpura Species 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000005250 Spontaneous Fractures Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N beta-Carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 235000010350 erythorbic acid Nutrition 0.000 description 2
- 239000004318 erythorbic acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 229940014144 folate Drugs 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229960003284 iron Drugs 0.000 description 2
- 229940026239 isoascorbic acid Drugs 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 235000015816 nutrient absorption Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 2
- 208000033808 peripheral neuropathy Diseases 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 235000011496 sports drink Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
- 101150018468 Abcg5 gene Proteins 0.000 description 1
- 101150084280 Abcg8 gene Proteins 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000002877 Artemisia absinthium Species 0.000 description 1
- 101150072027 BTD gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 238000001061 Dunnett's test Methods 0.000 description 1
- 240000000896 Dyera costulata Species 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010334 End Stage Liver Disease Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 239000005781 Fludioxonil Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 206010023648 Lactase deficiency Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 101150067145 SCARB1 gene Proteins 0.000 description 1
- 101150038470 SLC7A7 gene Proteins 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 101150103667 Slc15a1 gene Proteins 0.000 description 1
- 101150081328 Slc5a6 gene Proteins 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 206010041969 Steatorrhoea Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 1
- ZIALXKMBHWELGF-UHFFFAOYSA-N [Na].[Cu] Chemical compound [Na].[Cu] ZIALXKMBHWELGF-UHFFFAOYSA-N 0.000 description 1
- SLIUELDPAPMQIB-IDIVVRGQSA-N [Na].[Na].[C@@H]1([C@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O1)N1C=NC=2C(O)=NC=NC12 Chemical compound [Na].[Na].[C@@H]1([C@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O1)N1C=NC=2C(O)=NC=NC12 SLIUELDPAPMQIB-IDIVVRGQSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 235000013323 absinthe Nutrition 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- UGAPHEBNTGUMBB-UHFFFAOYSA-N acetic acid;ethyl acetate Chemical compound CC(O)=O.CCOC(C)=O UGAPHEBNTGUMBB-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 206010002022 amyloidosis Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000011444 chronic liver failure Diseases 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- LEVWYRKDKASIDU-UHFFFAOYSA-N cystine Chemical compound OC(=O)C(N)CSSCC(N)C(O)=O LEVWYRKDKASIDU-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000013110 gastrectomy Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- DQOCFCZRZOAIBN-WZHZPDAFSA-L hydroxycobalamin Chemical compound O.[Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O DQOCFCZRZOAIBN-WZHZPDAFSA-L 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 101150038846 slc46a1 gene Proteins 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0616—Cysteine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/062—Glutamine
Abstract
本發明提供含有胱胺酸及麩醯胺之至少一者作為有效成分的於消化道之吸收降低的改善用組成物,或於消化道之吸收的促進用組成物。 本發明之上述組成物,可良好地改善由各種原因所引起的於消化道之吸收的降低,特別是壓力或運動所致的於消化道之吸收的降低,又,可促進於消化道之吸收。
Description
[0001] 本發明係關於於消化道之吸收降低的改善用組成物。又,本發明係關於於消化道之吸收的促進用組成物。
[0002] 於消化道之營養素的消化及吸收,係以(1)於腔內之酵素所致之脂肪、蛋白質、碳水化合物之水解、(2)刷狀緣(brush border)酵素所致之消化及最終產物的攝入、(3)營養素之淋巴輸送的三階段進行,此等階段不管何者產生障礙,於消化道之吸收均會降低,產生營養素之吸收不良。 [0003] 於消化道之吸收降低,係因Billroth II法胃切除術、胃結腸瘻、胃腸吻合術之施術等所致於胃的混合不充分、迅速排出;膽道阻塞、慢性肝衰竭、慢性胰臟炎、囊腫纖維化症、乳糖酶缺乏症、胰臟癌等所致之消化酵素的不足;糖尿病、厚皮病、甲狀腺機能亢進症所續發之異常運動性、腸內細菌異常增殖等所致之消化道內環境的惡化;急性腸感染症、酒精、新黴素等所致之黏膜上皮的急性異常;類澱粉變性症、乳糜瀉病、克隆氏病等所致之黏膜上皮的慢性異常;無β脂蛋白血症、青銅色病、乳糜管阻塞淋巴瘤、結核、淋巴管擴張等所致之輸送障礙等而產生。 [0004] 又,消化道雖具有不使消化道內之有害異物侵入體內的系統,亦即消化道屏障機能,但有報導各種之壓力負荷會誘導消化道屏障機能之異常,因此所產生之異物進入,會引起消化道或各種臟器之發炎、免疫系統之擾亂(非專利文獻1)。 進一步地,報導有因激烈運動所致之消化道屏障機能的降低(非專利文獻2)。 該消化道屏障機能之降低,可認為會引起消化道之機能障礙,其結果,使消化道中之消化吸收能力降低。 [0005] 消化道中之吸收降低的狀態若持續時,因未被吸收而殘存於體內的物質,會出現下痢、脂肪便、腹部膨脹、產氣等之症狀。又,特定之營養素吸收不良,會引起貧血、紫癜、點狀出血、腕足痙攣、浮腫、舌炎、夜盲症、四肢、骨疼痛、病理性骨折、末梢神經障礙等症狀。 因此,期望有對因各種原因所引起之於消化道之吸收降低有效之改善用組成物。 特別是現代社會中,壓力係日常性持續負荷,其減輕多為困難。又,就維持運動選手等無法避免運動者的健康上,改善因壓力或運動所引起之於消化道之吸收降低之必要性亦高。 [先前技術文獻] [非專利文獻] [0006] [非專利文獻1]鈴木卓彌;上原紀念生物科學財團研究報告集26 1-6 (2012) [非專利文獻2]Kim van Wijck et al.; Plos One 6 (7) e22366 (2011)
[發明所欲解決之課題] [0007] 因而,本發明之目的為提供對因各種原因所引起之於消化道之吸收降低的改善用組成物,特別是可良好地改善因壓力或運動所引起之於消化道之吸收降低之改善用組成物。 [用以解決課題之手段] [0008] 本發明者等人為了解決上述課題而努力探討的結果,發現胱胺酸及麩醯胺之至少一者,可改善於消化道之吸收降低,而完成本發明。 又,本發明者等人,發現胱胺酸及麩醯胺之至少一者,會促進於消化道之吸收。 [0009] 亦即,本發明關於以下者。 [1]一種於消化道之吸收降低的改善用組成物,其含有胱胺酸及麩醯胺之至少一者作為有效成分。 [2]如[1]之組成物,其含有胱胺酸及麩醯胺。 [3]如[2]之組成物,其中胱胺酸與麩醯胺之含量比(胱胺酸:麩醯胺),以重量比計,為1:0.01~1:100。 [4]如[1]~[3]中任一項之組成物,其係於消化道之水之吸收降低的改善用組成物。 [5]如[1]~[3]中任一項之組成物,其係於消化道之營養素之吸收降低的改善用組成物。 [6]如[5]之組成物,其中營養素為選自由蛋白質、胜肽、胺基酸、糖質、脂質、維生素及礦物質所成之群的至少一者。 [7]如[6]之組成物,其中維生素為選自由維生素A、維生素B群、維生素D及維生素E所成之群的至少一者。 [8]如[1]~[7]中任一項之組成物,其係醫藥組成物。 [9]如[1]~[7]中任一項之組成物,其係食品組成物。 [10]一種於消化道之吸收降低的改善方法,其包含為了改善於消化道之吸收降低,使呈現於消化道之吸收降低的對象攝取或對其投與有效量之胱胺酸及麩醯胺之至少一者。 [11]如[10]之方法,其包含為了改善於消化道之吸收降低,使攝取或投與有效量之胱胺酸及麩醯胺。 [12]如[11]之方法,其包含以胱胺酸與麩醯胺之含量比(胱胺酸:麩醯胺)以重量比計為1:0.01~1:100使攝取或投與胱胺酸及麩醯胺。 [13]如[10]~[12]中任一項之方法,其係改善於消化道之水之吸收降低。 [14]如[10]~[12]中任一項之方法,其係改善於消化道之營養素之吸收降低。 [15]如[14]之方法,其中營養素為選自由蛋白質、胜肽、胺基酸、糖質、脂質、維生素及礦物質所成之群的至少一者。 [16]如[15]之方法,其中維生素為選自由維生素A、維生素B群、維生素D及維生素E所成之群的至少一者。 [17]一種於消化道之吸收的促進用組成物,其含有胱胺酸及麩醯胺之至少一者作為有效成分。 [18]如[17]之組成物,其係於消化道之營養素之吸收的促進用組成物。 [19]如[18]之組成物,其中營養素為選自由蛋白質、胜肽、胺基酸、糖質、脂質、維生素及礦物質所成之群的至少一者。 [20]如[17]~[19]中任一項之組成物,其係醫藥組成物。 [21]如[17]~[19]中任一項之組成物,其係食品組成物。 [22]一種於消化道之吸收的促進方法,其包含為了促進於消化道之吸收,使需要促進於消化道之吸收的對象攝取或對其投與有效量之胱胺酸及麩醯胺之至少一者。 [23]如[22]之方法,其係促進於消化道之營養素的吸收。 [24]如[23]之方法,其中營養素為選自由蛋白質、胜肽、胺基酸、糖質、脂質、維生素及礦物質所成之群的至少一者。 [發明之效果] [0010] 本發明之於消化道之吸收降低的改善用組成物,可改善由各種原因,特別是壓力或運動所引起的於消化道之吸收的降低。 亦即,本發明之於消化道之吸收降低的改善用組成物,可抑制透過消化道之水、營養素等的吸收,因壓力、運動等某種原因而降低,又,可由透過消化道之水、營養素等的吸收因某種原因而降低的狀態,提高至正常狀態或良好狀態。 [0011] 進一步地,本發明之於消化道之吸收的促進用組成物,可促進透過消化道之營養素等的吸收。
[0013] 本發明之於消化道之吸收降低的改善用組成物(以下,本說明書中亦稱為「本發明之組成物」),含有胱胺酸及麩醯胺之至少一者作為有效成分。 [0014] 本說明書中,「於消化道之吸收降低」,係指於腔內之酵素所致之脂肪、蛋白質、碳水化合物之水解;刷狀緣酵素所致之消化及最終產物之攝入;營養素之淋巴輸送等,因某種原因受到障礙,結果透過消化道之水、營養素等的吸收有所降低。 再者,本說明書中,「消化道」係指進行食物之消化吸收的器官,係咽頭、食道、胃、小腸(十二指腸、空腸、迴腸)及大腸。 又,本說明書中,「吸收降低的改善」,係指由上述透過消化道之水、營養素等的吸收降低受到抑制,或透過消化道之水、營養素等的吸收降低的狀態,提高至正常狀態或良好狀態。 [0015] 本發明之組成物中作為有效成分所含有之胱胺酸,亦即3,3’-二硫代雙(2-胺基丙酸);及麩醯胺,亦即2-胺基-4-胺甲醯基丁酸,係L-體、D-體、DL-體之任意者均可使用,較佳為L-體及DL-體、更佳為L-體。 [0016] 又,本發明中,胱胺酸及麩醯胺,不僅游離體,亦能夠以鹽的形態使用。本說明書中之「胱胺酸」及「麩醯胺」的用語,為亦包含鹽之概念。鹽之形態可列舉酸加成鹽或與鹼之鹽等,較佳為選擇藥理學上容許之鹽。 [0017] 具體而言,可列舉與無機鹼、有機鹼、無機酸、有機酸之鹽及與胺基酸之鹽等。 與無機鹼之鹽,例如可列舉與鋰、鈉、鉀等鹼金屬之鹽;與鎂、鈣等鹼土類金屬之鹽;銨鹽等。 與有機鹼之鹽,例如可列舉與單乙醇胺、二乙醇胺、三乙醇胺等烷醇胺之鹽;與嗎啉、哌啶等雜環式胺之鹽等。 與無機酸之鹽,例如可列舉與鹵化氫酸(鹽酸、氫溴酸、氫碘酸等)、硫酸、硝酸、磷酸等之鹽。 與有機酸之鹽,例如可列舉與甲酸、乙酸、丙酸等單羧酸之鹽;與草酸、丙二酸、蘋果酸、琥珀酸等飽和二羧酸之鹽;與馬來酸、富馬酸等不飽和二羧酸之鹽;與檸檬酸等三羧酸之鹽;與α-酮戊二酸等酮酸之鹽。 與胺基酸之鹽,可列舉與甘胺酸、丙胺酸等脂肪族胺基酸之鹽;與苯丙胺酸等芳香族胺基酸之鹽;與離胺酸等鹼性胺基酸之鹽;與天門冬胺酸、麩胺酸等酸性胺基酸之鹽;與焦麩胺酸等形成有內醯胺的胺基酸之鹽等。 [0018] 上述之鹽,分別亦可為水合物(含水鹽),該水合物例如可列舉1水合物~6水合物等。 [0019] 本發明中,上述游離體及鹽形態之「胱胺酸」及「麩醯胺」,分別可1種單獨使用、亦可組合2種以上使用。 本發明之目的中,對於「胱胺酸」及「麩醯胺」各自而言,較佳為游離體及鹽酸鹽等。 [0020] 本發明中,游離體及鹽之形態的胱胺酸及麩醯胺,係由天然存在之動植物等所萃取精製者或以化學合成法、發酵法、酵素法或基因重組法等所得到者均可使用,亦可利用由各公司所提供之市售製品。 [0021] 本發明之組成物,至少含有游離體及鹽形態之胱胺酸之1種以上,及游離體及鹽形態之麩醯胺之1種以上的任一者。 本發明之組成物中之胱胺酸的含量,相對於本發明之組成物中之胺基酸的全含量而言,較佳為0.1重量%以上、更佳為1重量%~90重量%、又更佳為5重量%~50重量%。 又,本發明之組成物中之麩醯胺的含量,相對於本發明之組成物中之胺基酸的全含量而言,較佳為0.1重量%以上、更佳為1重量%~90重量%、又更佳為5重量%~50重量%。 再者,本說明書中,本發明之組成物中之胱胺酸及麩醯胺的各自之含量,當該胺基酸以鹽的形態含有時,係以換算為游離體之含量表示。 [0022] 如後所述,胱胺酸與麩醯胺,分別對小腸之不同的消化吸收相關基因,抑制表現降低或使降低之表現回復,或促進表現增加,故本發明之組成物中,較佳為含有胱胺酸及麩醯胺雙方。 本發明之組成物含有胱胺酸及麩醯胺雙方時,此等之含量比(胱胺酸:麩醯胺),以重量比計,較佳為1:0.01~1:100、更佳為1:0.1~1:10。 [0023] 本發明之組成物,於胱胺酸及麩醯胺之至少一者以外,亦可進一步含有糖質、脂質、蛋白質、胱胺酸及麩醯胺以外之胺基酸、維生素、礦物質等之其他營養成分。 [0024] 本發明之組成物,可於胱胺酸及麩醯胺之至少一者,依需要添加其他營養成分或藥學上容許之添加劑,藉由製劑領域中眾所周知之製劑化手段,例如第十七修訂版日本藥典製劑總則[3]製劑各條所記載之方法等,使成為溶液、懸浮液、乳濁液等之液狀;凝膠、乳劑等之半固體狀;粉末、顆粒、錠劑、膠囊等之固體狀等各種形態。 [0025] 上述藥學上容許之添加劑,可依本發明之組成物的形態適當選擇,例如可列舉賦形劑、結合劑、崩解劑、潤滑劑、被覆劑、基劑、溶劑、溶解輔助劑、助溶劑、乳化劑、分散劑、懸浮劑、安定劑、黏稠劑、無痛劑、等張劑、pH調整劑、抗氧化劑、防腐劑、保存劑、調味劑、甘味劑、香料、著色劑等。 [0026] 具體而言,賦形劑例如可列舉碳酸鎂、糖類(葡萄糖、乳糖、玉米澱粉等)、糖醇(山梨醇、甘露醇等)等。 結合劑例如可列舉明膠、α化澱粉、部分α化澱粉、纖維素及其衍生物(結晶纖維素、羥基丙基纖維素等)等。 崩解劑例如可列舉交聯聚維酮、聚維酮、結晶纖維素等。 潤滑劑例如可列舉滑石、硬脂酸鎂等。 被覆劑例如可列舉甲基丙烯酸/甲基丙烯酸甲酯共聚物、甲基丙烯酸/丙烯酸乙酯共聚物、甲基丙烯酸甲酯/甲基丙烯酸丁酯/甲基丙烯酸二甲基胺基乙酯共聚物、丙烯酸乙酯/甲基丙烯酸甲酯/甲基丙烯酸氯化三甲基銨乙酯共聚物等。 [0027] 基劑例如可列舉動植物性油脂(橄欖油、可可脂、牛脂、麻油、硬化油、蓖麻油等)、蠟(卡拿巴蠟、蜜蠟等)、聚乙二醇等。 溶劑例如可列舉純水、注射用水、一元醇(乙醇等)、多元醇(甘油等)等。 溶解輔助劑例如可列舉丙二醇、中鏈脂肪酸三甘油酯等。 [0028] 助溶劑、乳化劑、分散劑及懸浮劑,例如可列舉山梨醇酐脂肪酸酯、甘油脂肪酸酯、聚氧乙烯山梨醇酐脂肪酸酯(聚山梨醇酯20、聚山梨醇酯80等)、聚氧乙烯硬化蓖麻油、蔗糖脂肪酸酯等之界面活性劑等。 [0029] 安定劑例如可列舉己二酸、β-環糊精、乙二胺、乙二胺四乙酸鈉等。 黏稠劑例如可列舉水溶性高分子(聚丙烯酸鈉、羧基乙烯基聚合物等)、多糖類(海藻酸鈉、三仙膠、龍膠等)等。 無痛劑例如可列舉胺基安息香酸乙酯、氯丁醇、丙二醇、苯甲醇等。 等張劑例如可列舉氯化鉀、氯化鈉、山梨醇、生理食鹽水等。 pH調整劑例如可列舉鹽酸、硫酸、乙酸、檸檬酸、乳酸、氫氧化鈉、氫氧化鉀等。 [0030] 抗氧化劑例如可列舉二丁基羥基甲苯(BHT)、丁基羥基苯甲醚(BHA)、dl-α-生育酚、異抗壞血酸等。 防腐劑及保存劑例如可列舉對羥基苯甲酸酯(對羥基苯甲酸甲酯等)、苯甲醇、去氫乙酸鈉、山梨酸等。 [0031] 調味劑例如可列舉抗壞血酸、赤藻糖醇、L-麩胺酸鈉等。 甘味劑例如可列舉阿斯巴甜、甘草萃取物、糖精等。 香料例如可列舉l-薄荷腦、d-樟腦、香草醛等。 著色劑例如可列舉溚色素(食用紅色2號、食用藍色1號、食用黃色4號等)、無機顏料(三二氧化鐵、黃氧化鐵、黑氧化鐵等)、天然色素(薑黃萃取液、β-胡蘿蔔素、銅葉綠酸鈉等)等。 [0032] 本發明中,上述添加劑,可使用1種或2種以上。 [0033] 本發明之組成物之每1日的攝取量或投與量,係依所應用之對象(以下,本說明書中,亦稱為「應用對象」)之種類、性別、年齡、於應用對象所觀察到的於消化道之吸收降低的狀態及其程度,以及本發明之組成物的形態、投與方法等而適當決定,當應用對象為人類成人時,以胱胺酸及麩醯胺之至少一者之量(換算為游離體之量)(合併使用胱胺酸及麩醯胺時係此等之總量(換算為游離體之量的總量))計,通常係0.1mg/kg~5000mg/kg、較佳為1mg/kg~2500mg/kg、更佳為10mg/kg~1000mg/kg。 上述之量可1次攝取或投與,亦可分為1日數次(2~3次)攝取或投與。 又,本發明之組成物之攝取或投與期間,亦依於應用對象所觀察到的於消化道之吸收降低的狀態及其程度等而適當設定。於消化道之吸收降低,為因日常所負荷之壓力所引起時,或因持續實施之運動所引起時等,本發明之組成物,較佳為長期間持續攝取或投與。 [0034] 本發明之組成物,可為單位包裝形態。本說明書中,「單位包裝形態」,係指以特定量(例如每1次之攝取量或投與量等)為1單位,將該1單位或2單位以上填充於一個容器中,或包裝為包裝體等,而經收納的形態,例如,以每1次之攝取量或投與量為1單位之單位包裝形態,係稱為「每1次之攝取量或投與量單位之包裝形態」。單位包裝形態所用的容器或包裝體,可依本發明之組成物的形態等而適當選擇,例如可列舉紙製之容器或袋體、塑膠製之容器或袋體、囊袋(pouch)、鋁罐、鋼罐、玻璃瓶、寶特瓶、PTP(press through pack)包裝片等。 [0035] 本發明之組成物之應用對象,可列舉哺乳動物(例如人類、猴子、小鼠、大鼠、天竺鼠、倉鼠、兔子、貓、狗、牛、馬、驢子、豬、羊等)或鳥類(例如鴨、雞、鵝、火雞等)等。 將本發明之組成物應用於人類以外之應用對象動物(以下亦僅稱為「對象動物」)時,本發明之組成物之攝取量或投與量,只要依對象動物之種類、性別、體重等來適當設定即可。 [0036] 本發明之組成物,可良好地改善由於各種原因而產生之於消化道之水或營養素等之吸收降低。其中尤對因由壓力負荷或運動所誘導之消化道障礙等而產生的水、營養素等之吸收降低更為有效。 [0037] 此處,可藉由本發明之組成物改善於消化道之吸收降低的營養素,可列舉植物性蛋白質(大豆蛋白質等)、動物性蛋白質等之蛋白質;胜肽;必須胺基酸(白胺酸、異白胺酸、纈胺酸、蘇胺酸等)、非必須胺基酸(甘胺酸、丙胺酸等)等之胺基酸;單糖類(葡萄糖、果糖等)、二糖類(麥芽糖、蔗糖等)、寡糖(麥芽三糖等)、葡聚糖、糊精、澱粉等之糖質;單純脂質(醯基甘油等)、複合脂質(甘油磷脂質、鞘磷脂質、甘油糖脂質、鞘糖脂質等)、衍生脂質(脂肪酸、類胡蘿蔔素、膽固醇等)等之脂質;維生素A(視網醇、視網醛、視網酸等)、維生素B群(維生素B1
(硫胺素)、維生素B2
(核黃素)、菸鹼酸(菸鹼酸、菸鹼酸醯胺)、維生素B6
(吡哆醛、吡哆胺、吡哆醇)、生物素、葉酸、泛酸、維生素B12
(氰基鈷胺素、羥鈷胺素)等)、維生素C(抗壞血酸等)、維生素D(膽鈣化醇、麥角鈣化固醇等)、維生素E(生育酚、參雙鍵生殖酚等)、維生素K(葉醌、甲萘醌(維生素K2)、甲萘醌(維生素K3)等)等之維生素;氯化鈉、氯化鉀、氯化鈣、磷酸二鉀、硫酸鎂等之礦物質等。 [0038] 本發明之組成物,如後所述,對小腸上皮細胞中,營養素吸收相關的轉運蛋白(solute carrier transporter群(SLC家族)、ATP binding cassette transporter (ABC)群(ABC家族)、葡萄糖轉運蛋白(GLUT)、鈉依賴性葡萄糖轉運蛋白(SGLT)),或水或礦物質吸收相關的水孔蛋白之基因表現,會抑制壓力負荷或運動所致的降低,或使降低之表現回復,或增加表現,可改善水或營養素於消化道之吸收的降低。 關於維生素之吸收降低,特別是對生物素酶、葉酸轉運蛋白、鈉依賴性多維生素轉運蛋白,及脂溶性維生素(維生素A、維生素D、維生素E等)之吸收相關的轉運蛋白(清道夫受體類型B等)的基因之表現,會抑制壓力負荷或運動所致的降低,或使降低之表現回復,或增加表現,可改善維生素B群(生物素、葉酸、泛酸等)及脂溶性維生素(維生素A、維生素D、維生素E等)於消化道之吸收降低。 [0039] 本發明之組成物,可改善於消化道之水或營養素之吸收降低,可防止因水或營養素之吸收不良所產生之各種症狀的表現,或改善前述症狀。 因水之吸收不良所產生之症狀,可列舉脫水症、高體溫症等。 因營養素之吸收不良所產生之症狀,可列舉鐵之吸收不良所致的低色素性貧血;維生素B12
、葉酸之吸收不良所致的大紅血球性貧血;維生素K及維生素C之吸收不良所致的出血、紫癜、點狀出血;鈣、鎂之吸收不良所致的腕足痙攣;蛋白質之吸收不良所致的浮腫;維生素B2
及B12
、葉酸、菸鹼酸、鐵之吸收不良所致的舌炎;維生素A之吸收不良所致的夜盲症;鉀、鎂、鈣、維生素D之吸收不良所致的四肢、骨疼痛、病理性骨折;維生素B1
、B6
、B12
之吸收不良所致的末梢神經障礙等。 [0040] 因此,本發明之組成物,可適合地使呈現於消化道之水、營養素等之吸收降低者攝取或對其投與。 如上所述,本發明之組成物,對於因壓力或運動所造成之於消化道之水、營養素等之吸收降低更為有效,因此可更適合地使因壓力負荷或運動而呈現於消化道之水、營養素等之吸收降低者攝取或對其投與。 因此,本發明之組成物,可為了改善日常暴露於壓力者或必須日常持續運動者(例如進行運動療法之患者等),或日常進行激烈運動之運動選手等中,於消化道之水、營養素等之吸收降低,而更適合地攝取或投與。 再者,使必須日常持續運動者或運動選手等攝取本發明之組成物或對其投與時,本發明之組成物可於進行運動前、運動途中或運動後的任意情況攝取或投與。 [0041] 本發明之組成物,能夠以醫藥組成物(以下,本說明書中亦稱為「本發明之醫藥組成物」)的形態提供。 本發明之醫藥組成物,可直接或依需要添加上述藥學上容許之添加劑,來作為錠劑、被覆錠劑、咀嚼錠、丸劑、(微)膠囊劑、顆粒劑、細粒劑、散劑、酏劑、檸檬劑、糖漿劑、懸浮劑、乳劑、經口膠狀劑等之經口製劑;溶液狀、懸浮液狀、乳液狀等之注射劑;用時溶解或懸浮來使用的固體狀之注射劑;輸液劑、持續性注射劑等之注射用製劑、經管液劑等之劑型。 [0042] 本發明之醫藥組成物,可適合對呈現於消化道之水、營養素等之吸收降低,具有水、營養素等之吸收不良所致症狀的患者,或呈現於消化道之水、營養素等之吸收降低,有表現水、營養素等之吸收不良所致症狀之虞的患者等進行投與。 又,本發明之醫藥組成物可更適合對因壓力造成的消化道障礙等,而呈現於消化道之水、營養素等之吸收降低的患者;持續運動療法,因運動而呈現於消化道之水、營養素等之吸收降低的患者;或因激烈運動,而招致於消化道之水、營養素等之吸收降低者進行投與。 本發明之醫藥組成物,對於上述應用對象,係以每1日,以胱胺酸及麩醯胺之至少一者的投與量成為上述每1日之投與量的方式進行投與。 [0043] 進一步地,本發明之組成物,可添加於各種食品來攝取。添加本發明之組成物的食品並無特殊限制,只要係一般供飲食或甜點之形態的食品,則何者皆可。 例如,可將本發明之組成物添加於清涼飲料水等之飲料中,依期望添加適當的風味,來作為飲料劑。 更具體而言,本發明之組成物,例如可添加於果汁飲料、運動飲料等之清涼飲料水;牛乳、優格等之乳製品;果凍、巧克力、糖果等之糖食等。 [0044] 本發明之組成物,較佳相對於每1日攝取之量的上述各種食品而言,以胱胺酸及麩醯胺之至少一者的攝取量,成為上述每1日之攝取量的方式添加。 [0045] 又,本發明之組成物,能夠以食品組成物(以下,本說明書中亦稱為「本發明之食品組成物」)的形態提供。 本發明之食品組成物,可直接或依需要添加一般的食品添加物,藉由通常之食品製造技術,而作為液狀、懸浮液狀、乳狀、凝膠狀、乳劑狀、粉末狀、顆粒狀、片狀、膠囊狀、錠劑狀等各種形態。 進一步地,本發明之食品組成物,可將本發明之組成物添加於各種食品原材料,依需要添加一般的食品添加物,來作為清涼飲料水(果汁飲料、運動飲料、咖啡飲料、茶系飲料等)、乳製品(乳酸菌飲料、發酵乳、奶油、乳酪、優格、加工乳、脫脂乳等)、畜肉製品(火腿、香腸、漢堡排等)、魚漿製品(魚板、竹輪、薩摩炸魚餅等)、蛋製品(日式蛋包卷、蛋豆腐等)、糖食(餅乾、果凍、口香糖、糖果、零食、冷點心等)、麵包、麵類、醃漬物、魚乾、佃煮、湯、調味料等各種形態之食品,亦可為瓶裝食品、罐裝食品、殺菌袋(retort pouch)食品。 [0046] 上述食品添加物,可列舉製造用劑(鹼水、結著劑等)、增黏安定劑(三仙膠、羧基甲基纖維素鈉等)、凝膠化劑(明膠、寒天、鹿角菜膠等)、膠基質(乙酸乙烯酯樹脂、節路頓膠(jelutong)、人心果等)、乳化劑(甘油脂肪酸酯、蔗糖脂肪酸酯、皂素、卵磷脂等)、保藏劑(安息香酸、安息香酸鈉、山梨酸、山梨酸鉀、ε-聚離胺酸等)、抗氧化劑(抗壞血酸、異抗壞血酸、兒茶素等)、光澤劑(蟲膠、石蠟、蜜蠟等)、防黴劑(噻苯達唑(tiabendazole)、護汰寧(fludioxonil)等)、膨脹劑(碳酸氫鈉、葡萄糖酸δ-內酯、明礬等)、甘味料(阿斯巴甜、艾司沙芬(acesulfame)鉀、甘草萃取物等)、苦味料(咖啡因、柚苷、苦艾萃取物等)、酸味料(檸檬酸、酒石酸、乳酸等)、調味料(L-麩胺酸鈉、5’-肌苷酸二鈉等)、著色料(胭脂樹紅色素、薑黃色素、山黃梔色素等)、香料(乙醯乙酸乙酯、大茴香醛等之合成香料、柑橘、薰衣草等之天然香料)等。 本發明中,上述食品添加物,可使用1種或2種以上。 [0047] 本發明之食品組成物,可適合地使呈現於消化道之水、營養素等之吸收降低者,或有呈現於消化道之水、營養素等之吸收降低之虞者攝取。 又,本發明之食品組成物,可更適合地使日常暴露於壓力,有呈現於消化道之水、營養素等之吸收降低之虞者,或進行運動療法者或運動選手等,因運動而有呈現於消化道之水、營養素等之吸收降低之虞者攝取。 [0048] 因此,本發明之食品,亦可作為於消化道之水、營養素等之吸收降低的改善用之保健機能食品(特定保健用食品、營養機能食品、機能性表示食品等)、特別用途食品(病患用食品、高齡者用食品等)、健康輔助食品、膳食補充劑等提供。 [0049] 本發明之食品組成物,較佳使上述應用對象,以胱胺酸及麩醯胺之至少一者的攝取量成為上述每1日之攝取量的方式攝取。 [0050] 上述本發明之組成物,不僅改善於消化道之吸收的降低,亦顯示促進於消化道之吸收的效果。 因此,本發明之組成物,亦作為於消化道之吸收的促進用組成物而發揮機能。此處,「於消化道之吸收的促進」,係指使於消化道之營養素等之吸收,較通常更為提高。 [0051] 因此,本發明亦提供含有胱胺酸及麩醯胺之至少一者作為有效成分的於消化道之吸收的促進用組成物。 本發明之於消化道之吸收的促進用組成物,能夠以醫藥組成物或食品組成物的形態提供,又,亦可添加於食品來攝取。 關於本發明之於消化道之吸收的促進用組成物,胱胺酸及麩醯胺之至少一者的每1日之攝取量或投與量、每1日之攝取或投與次數、攝取或投與期間等,係與上述於消化道之吸收降低的改善用組成物之情況相同。 本發明之於消化道之吸收的促進用組成物,可適合使需要更多營養素者,例如從事作業量多之勞動者、日常進行激烈運動之運動選手、成長期之兒童、青少年等攝取或對其投與。 [0052] 進一步地,本發明亦提供有必要改善於消化道之吸收降低的對象動物之於消化道之吸收降低的改善方法(以下,本說明書中亦稱為「本發明之方法」)。 [0053] 本發明之方法,包含使有必要改善於消化道之吸收降低的對象動物,攝取改善該對象動物之於消化道之吸收降低的有效量之胱胺酸及麩醯胺之至少一者,或對其投與。 [0054] 本發明之方法中的對象動物,可列舉哺乳動物(例如人類、猴子、小鼠、大鼠、天竺鼠、倉鼠、兔子、貓、狗、牛、馬、驢子、豬、羊等),或鳥類(例如鴨、雞、鵝、火雞等)等。 [0055] 本發明之方法,有效於改善因各種原因所產生的於消化道之吸收降低,更有效於改善因壓力或運動所造成的於消化道之吸收降低。 [0056] 人類的情況時,本發明之方法,適合應用於呈現於消化道之吸收降低的患者,特別是因壓力所致之消化道障礙等而呈現於消化道之吸收降低者,或日常暴露於壓力,有招致於消化道之吸收降低之虞者,或者進行運動療法之患者或運動選手,呈現於消化道之吸收降低,或有招致於消化道之吸收降低之虞者等。 [0057] 本發明之方法中的胱胺酸及麩醯胺之至少一者的有效量,係依對象動物之種類、年齡、性別、於消化道之吸收降低的症狀或程度等來決定,但本發明之組成物中,對於人類及人類以外之對象動物,能夠以上述次數及期間將與上述攝取量或投與量相同之量進行攝取或投與。 [0058] 進一步地,本發明之方法中,攝取或投與胱胺酸及麩醯胺之至少一者的方法,可列舉經口投與、經腸經管投與、輸液投與等,但由於不需於醫療機關在醫師之指導監督下進行、可簡便地攝取,故經口投與較佳。 [0059] 如上所述,胱胺酸及麩醯胺之至少一者,不僅改善於消化道之吸收的降低,亦具有促進於消化道之吸收的效果,因此本發明亦提供一種於消化道之吸收的促進方法,其包含使必須促進於消化道之吸收的對象動物,攝取促進該對象動物之於消化道之吸收的有效量之胱胺酸及麩醯胺之至少一者,或對其投與。 胱胺酸及麩醯胺之至少一者的有效量、攝取或投與之次數及期間等,係與於消化道之吸收降低的改善方法之情況相同。 本發明之於消化道之吸收的促進方法,可適合應用於從事作業量多之勞動者、日常進行激烈運動之運動選手、成長期之兒童、青少年等需要更多營養素者。 [實施例] [0060] 以下藉由實施例更詳細說明本發明。 [0061] [試驗例1]胱胺酸及麩醯胺對小腸之消化吸收相關基因之表現的效果之探討 將7週齡之雄性CD2F1小鼠(日本Charles River股份有限公司)分群為4群(「Sed」、「Ex」、「Ex+Gln」及「Ex+Cys2」之各群)(n=6/群),對Sed群及Ex群,係將標準精製飼料(AIN-93G組成)、對Ex+Gln群,係將藉著與酪蛋白置換,而添加有麩醯胺(2重量%)之標準精製飼料(AIN-93G組成)、對Ex+Cys2群,係將藉著與酪蛋白置換,而添加有胱胺酸(2重量%)之標準精製飼料(AIN-93G組成),分別使其攝取7日。之後,使各群絕食一晩,對於Ex群、Ex+Gln群及Ex+Cys2群,使其於旋轉車內跑行4小時(速度=10.5m/min)。於使Ex群、Ex+Gln群及Ex+Cys2群進行跑行運動其間,對Sed群繼續絕食。跑行結束1小時後由各群小鼠採取小腸,使用Rneasy Lipid Tissue Mini Kit (QIAGEN公司)萃取total RNA。全面性基因表現測定係使用GeneChip Mouse Genome 430 2.0(3’IVT)陣列 (Affymetrix公司)。對於各群之基因表現量的差異,係於單因子變異數分析(one-way analysis of variance)之後進行丹內特檢定(Dunnett's test)。 [0062] 將分別編碼蛋白質及胜肽之吸收相關的胜肽轉運蛋白、胺基酸之吸收相關的胺基酸轉運蛋白、脂質或脂溶性維生素之吸收相關的清道夫受體類型B、膽固醇之吸收相關的ABC蛋白質G8及ABC蛋白質G5、葉酸之吸收相關的葉酸轉運蛋白、生物素之吸收相關的生物素酶、泛酸、生物素及硫辛酸之吸收相關的鈉依賴性多維生素轉運蛋白,以及水及礦物質之吸收相關的水孔蛋白的基因(Slc15a1、Slc7a7、Scarb1、Abcg8、Abcg5、Slc46a1、Btd、Slc5a6及Aqa3)之表現量,以各自之mRNA量示於圖1~9。各群之mRNA量的測定結果,係以6隻小鼠之平均值±平均值的標準差表示。 [0063] 如圖1~圖9所示,相較於攝取標準精製飼料且未運動之群(Sed)而言,攝取標準精製飼料且運動之群(Ex)中,上述各基因之表現量降低(胜肽轉運蛋白、清道夫受體類型B之各基因為P<0.1,顯著傾向;胺基酸轉運蛋白、葉酸轉運蛋白之各基因為P<0.05,顯著;ABC蛋白質G8、ABC蛋白質G5、生物素酶、鈉依賴性多維生素轉運蛋白、水孔蛋白之各基因為P<0.01,顯著)。由該結果,確認到藉由4小時之跑行運動,蛋白質、胜肽、胺基酸、脂質、維生素、礦物質及水之吸收有降低。 [0064] 另一方面,如圖1、圖5、圖7~圖9所示,相較於攝取標準精製飼料且運動之群(Ex)而言,攝取添加有胱胺酸之標準精製飼料且運動之群(Ex+Cys2)中,胜肽轉運蛋白、ABC蛋白質G5、生物素酶、鈉依賴性多維生素轉運蛋白及水孔蛋白的各基因之表現有增加(胜肽轉運蛋白、生物素酶、水孔蛋白之各基因為P<0.01,顯著;ABC蛋白質G5、鈉依賴性多維生素轉運蛋白為P<0.05,顯著)。 又,如圖2~圖4、圖6、圖7、圖9所示,相較於攝取標準精製飼料且運動之群(Ex)而言,攝取添加有麩醯胺之標準精製飼料且運動之群(Ex+Gln)中,胺基酸轉運蛋白、清道夫受體類型B、ABC蛋白質G8、葉酸轉運蛋白、生物素酶及水孔蛋白的各基因之表現有增加(胺基酸轉運蛋白基因為P=0.1,為顯著傾向;清道夫受體類型B基因為P<0.1,為顯著傾向;ABC蛋白質G8、葉酸轉運蛋白之各基因為P<0.05,顯著;生物素酶、水孔蛋白之各基因為P<0.01,顯著)。 由上述結果,顯示出胱胺酸及麩醯胺會改善運動所致之水或營養素之吸收的降低。又,觀察到於胱胺酸與麩醯胺,表現降低之抑制或回復、或促進表現增加之小腸的消化吸收相關基因不同。 因此,暗示了欲有效改善運動所致之水及營養素之吸收降低,較佳為合併使用胱胺酸及麩醯胺。 [0065] [試驗例2]運動及胱胺酸對小腸之糖質吸收及鈉依賴性葡萄糖轉運蛋白基因表現的效果之探討 將7週齡之雄性CD2F1小鼠(日本Charles River股份有限公司)分群為3群(「Sed」、「Ex」、及「Ex+Cys2」之各群)(n=12/群),對Sed群及Ex群,係將標準精製飼料(AIN-93G組成)、對Ex+Cys2群,係將藉著與酪蛋白置換,而添加有胱胺酸(2重量%)之標準精製飼料(AIN-93G組成),分別使其攝取7日。之後,使各群絕食一晩,對於Ex群及Ex+Cys2群,使其於旋轉車內跑行4小時(速度=10.5m/min)。於使Ex群及Ex+Cys2群進行跑行運動其間,對於Sed群繼續絕食。跑行一結束後即採取小腸,遵照KirK等之方法(ADVANCES In Physiology Education 37 (4) 415-426 (2013))製作腸道反轉樣品。再者,腸道反轉樣品,係使用自幽門部起4cm之部位往下8cm的部分。 於所製作之各群的腸道反轉樣品之漿膜側及絨毛側,分別添加含有10mM葡萄糖之Ringer緩衝液,於氧供給下、37℃進行90分鐘培置(incubation)。之後,取出腸道反轉樣品,使用葡萄糖測定用套組(「葡萄糖CII Test Wako」(和光純藥工業股份有限公司))測定漿膜側及絨毛側之Ringer緩衝液中的葡萄糖濃度。各群之葡萄糖吸收能力,係由絨毛側與漿膜側之葡萄糖濃度的差異算出。 進一步地,由腸道反轉樣品之製作所用的小腸之一部分,使用Rneasy Lipid Tissue Mini Kit(QIAGEN公司)萃取total RNA。鈉依賴性葡萄糖轉運蛋白基因(SGLT1)表現之測定,係使用QuantStudio 12K Flex Real-Time PCR System (Thermo Fisher Scientific公司)。各群之葡萄糖吸收能力及基因表現量之差異,係於單因子變異數分析之後進行丹內特檢定。 [0066] 關於各群之葡萄糖吸收能力,係藉由絨毛側與漿膜側之葡萄糖濃度差異而示於圖10。又,關於鈉依賴性葡萄糖轉運蛋白基因(SGLT1)表現量,係藉由mRNA量而示於圖11。此等係以12隻小鼠之平均值±平均值的標準差表示。 [0067] 如圖10所示,相較於攝取標準精製飼料且未運動之群(Sed)而言,攝取標準精製飼料且運動之群(Ex)中,葡萄糖吸收能力降低。 另一方面,相較於攝取標準精製飼料且運動之群(Ex)而言,攝取添加有胱胺酸之標準精製飼料且運動之群(Ex+Cys2)中,葡萄糖吸收能力顯著(P<0.05)提高。 進一步地,由於Ex+Cys2之葡萄糖之吸收能力,較Sed群更高,故可觀察到藉由胱胺酸攝取,不僅改善了運動所致之葡萄糖吸收能力的降低,且葡萄糖吸收能力提高。 [0068] 又,如圖11所示,相較於攝取標準精製飼料且未運動之群(Sed)而言,攝取標準精製飼料且運動之群(Ex)中,葡萄糖之吸收相關的鈉依賴性葡萄糖轉運蛋白之基因(SGLT1)之表現增加(P<0.01,為顯著)。進而,相較於攝取標準精製飼料且運動之群(Ex)而言,攝取添加有胱胺酸之標準精製飼料且運動之群(Ex+Cys2)中,觀察到SGLT1之表現增加的傾向(P<0.1,為顯著傾向)。 [0069] 由試驗例2之上述結果,確認到葡萄糖吸收能力雖因4小時之跑行運動而降低,但藉由胱胺酸之攝取,其降低得到改善,進一步地,藉由胱胺酸之攝取,葡萄糖吸收能力較通常水準更為增強。 又,確認到胱胺酸會使得鈉依賴性葡萄糖轉運蛋白(SGLT1)基因之表現,較通常更為增加。 [0070] [試驗例3]非運動時胱胺酸對小腸之糖質吸收的效果之探討 將7週齡之雄性CD2F1小鼠(日本Charles River股份有限公司)分群為2群(「Sed」及「Sed+Cys2」之各群)(n=6/群),對Sed群係將標準精製飼料(AIN-93G組成)、對Sed+Cys2群係將藉著與酪蛋白置換,而添加有胱胺酸(2重量%)之標準精製飼料(AIN-93G組成),分別使其攝取7日。接著,使各群絕食一晩後採取小腸,遵照KirK等之方法(ADVANCES In Physiology Education 37 (4) 415-426 (2013)),製作腸道反轉樣品。再者,腸道反轉樣品,係使用自幽門部起4cm之部位往下8cm的部分。 於各群之腸道反轉樣品的漿膜側及絨毛側,分別添加含有10mM葡萄糖之Ringer緩衝液,於氧供給下、37℃進行90分鐘培置。之後,取出腸道反轉樣品,使用葡萄糖測定用套組(「葡萄糖CII Test Wako」(和光純藥工業股份有限公司))測定漿膜側及絨毛側之Ringer緩衝液中的葡萄糖濃度。各群之葡萄糖吸收能力,係由絨毛側與漿膜側之葡萄糖濃度的差異算出。各群之葡萄糖吸收能力之差異,係進行2群間比較t-檢定。 [0071] 關於各群之葡萄糖吸收能力,係藉由絨毛側與漿膜側之葡萄糖濃度的差異而示於圖12。葡萄糖濃度之差異的測定結果,係以6隻小鼠之平均值±平均值的標準差表示。 [0072] 如圖12所示,相較於攝取標準精製飼料之群(Sed)而言,攝取添加有胱胺酸之標準精製飼料之群(Sed+Cys2)中,可觀察到葡萄糖吸收能力提高。 由上述試驗例3之結果,確認到非運動時,藉由胱胺酸之攝取,葡萄糖吸收能力會提高,葡萄糖之吸收受到促進。 [0073] [試驗例4] 胱胺酸及麩醯胺之合併攝取對運動時之小腸的糖質吸收之效果的探討 將7週齡之雄性CD2F1小鼠(日本Charles River股份有限公司)分群為3群(「Ex」、「Ex+CG1」及「Ex+CG2」之各群)(n=6~8/群),對Ex群係將標準精製飼料(AIN-93G組成)、對Ex+CG1群係將藉著與酪蛋白置換,而添加有胱胺酸(0.6重量%)及麩醯胺(2.0重量%)之標準精製飼料(AIN-93G組成)、對Ex+CG2群係將藉著與酪蛋白置換,而添加有胱胺酸(2.0重量%)及麩醯胺(2.0重量%)之標準精製飼料(AIN-93G組成),分別使其攝取7日。 之後,使各群絕食一晩,使其於旋轉車內跑行4小時(速度=10.5m/min)。跑行一結束後即採取小腸,遵照KirK等之方法(ADVANCES In Physiology Education 37 (4) 415-426 (2013))製作腸道反轉樣品。再者,腸道反轉樣品,係使用自幽門部起4cm之部位往下8cm的部分。 於所製作之各群之腸道反轉樣品的漿膜側及絨毛側,分別添加含有10mM葡萄糖之Ringer緩衝液,於氧供給下、37℃進行90分鐘培置。之後,取出腸道反轉樣品,使用葡萄糖測定用套組(「葡萄糖CII Test Wako」(和光純藥工業股份有限公司))測定漿膜側及絨毛側之Ringer緩衝液中的葡萄糖濃度。各群之葡萄糖吸收能力,係由絨毛側與漿膜側之葡萄糖濃度的差異算出。 各群之葡萄糖吸收能力之差異,係於單因子變異數分析之後,進行丹內特檢定。 [0074] 關於各群之葡萄糖吸收能力,係藉由絨毛側與漿膜側之葡萄糖濃度的差異而示於圖13。葡萄糖濃度之差異的測定結果,係以6~8隻小鼠之平均值±平均值的標準差表示。 [0075] 如圖13所示,相較於攝取標準精製飼料且運動之群(Ex)而言,攝取添加有胱胺酸與麩醯胺之標準精製飼料之群(Ex+CG1及Ex+CG2)中,可觀察到葡萄糖吸收能力提高的傾向(Ex與Ex+CG2之間係P<0.1,為顯著傾向)。 由上述試驗例4之結果,確認到運動時,藉由合併攝取胱胺酸與麩醯胺,葡萄糖吸收能力提高,葡萄糖之吸收受到促進。 [0076] [實施例1]於消化道之吸收降低改善用組成物 將胱胺酸及麩醯胺混合,使得以重量比計成為7:30,作為實施例1之製劑。 [產業上之可利用性] [0077] 如以上詳述,藉由本發明,可提供可良好地改善由各種原因所致之於消化道之水、營養素等之吸收降低的於消化道之吸收降低的改善用組成物。 本發明之於消化道之吸收降低的改善用組成物,可抑制透過消化道之吸收的降低,又,可將透過消化道之吸收,由降低之狀態提高至正常狀態或良好狀態。 本發明之於消化道之吸收降低的改善用組成物,對壓力或運動所致之於消化道之吸收的降低特別有效。 [0078] 又,藉由本發明,可提供可促進於消化道之營養素等之吸收的於消化道之吸收的促進用組成物。 藉由本發明之於消化道之吸收的促進用組成物,可提高營養素等之利用效率。 [0079] 本案係以於日本國申請的特願2016-209926為基礎,其內容全部包含於本說明書中。
[0012] [圖1]表示試驗例1中,運動及胱胺酸對胜肽轉運蛋白基因之表現的效果之圖。圖中,「§」為P<0.1,表示觀察到顯著傾向之差異,「**」為P<0.01,表示統計上顯著。 [圖2]表示試驗例1中,運動及麩醯胺對胺基酸轉運蛋白基因之表現的效果之圖。圖中,「*」為P<0.05,表示統計上顯著。 [圖3]表示試驗例1中,運動及麩醯胺對清道夫受體類型B基因之表現的效果之圖。圖中,「§」為P<0.1,表示觀察到顯著傾向之差異。 [圖4]表示試驗例1中,運動及麩醯胺對ABC蛋白質G8基因之表現的效果之圖。圖中,「*」為P<0.05,表示統計上顯著,「**」為P<0.01,表示統計上顯著。 [圖5]表示試驗例1中,運動及胱胺酸對ABC蛋白質G5基因之表現的效果之圖。圖中,「*」為P<0.05,表示統計上顯著,「**」為P<0.01,表示統計上顯著。 [圖6]表示試驗例1中,運動及麩醯胺對葉酸轉運蛋白基因之表現的效果之圖。圖中,「*」為P<0.05,表示統計上顯著。 [圖7]表示試驗例1中,運動以及麩醯胺及胱胺酸對生物素酶基因之表現的效果之圖。圖中,「**」為P<0.01,表示統計上顯著。 [圖8]表示試驗例1中,運動及胱胺酸對鈉依賴性多維生素轉運蛋白基因之表現的效果之圖。圖中,「*」為P<0.05,表示統計上顯著,「**」為P<0.01,表示統計上顯著。 [圖9]表示試驗例1中,運動以及麩醯胺及胱胺酸對水孔蛋白基因之表現的效果之圖。圖中,「**」為P<0.01,表示統計上顯著。 [圖10]表示試驗例2中,運動及胱胺酸對葡萄糖吸收能力的效果之圖。圖中,「*」為P<0.05,表示統計上顯著。 [圖11]表示試驗例2中,運動及胱胺酸對鈉依賴性葡萄糖轉運蛋白基因之表現的效果之圖。圖中,「§」為P<0.1,表示觀察到顯著傾向之差異,「**」為P<0.01,表示統計上顯著。 [圖12]表示試驗例3中,胱胺酸對非運動時之葡萄糖吸收能力的效果之圖。 [圖13]表示試驗例4中,胱胺酸及麩醯胺之合併攝取對運動時之葡萄糖吸收能力的效果之圖。圖中,「§」為P<0.1,表示觀察到顯著傾向之差異。
Claims (14)
- 一種於消化道之吸收降低的改善用組成物,其含有胱胺酸及麩醯胺之至少一者作為有效成分。
- 如請求項1之組成物,其含有胱胺酸及麩醯胺。
- 如請求項2之組成物,其中胱胺酸與麩醯胺之含量比(胱胺酸:麩醯胺),以重量比計,為1:0.01~1:100。
- 如請求項1~3中任一項之組成物,其係於消化道之水之吸收降低的改善用組成物。
- 如請求項1~3中任一項之組成物,其係於消化道之營養素之吸收降低的改善用組成物。
- 如請求項5之組成物,其中營養素為選自由蛋白質、胜肽、胺基酸、糖質、脂質、維生素及礦物質所成之群的至少一者。
- 如請求項6之組成物,其中維生素為選自由維生素A、維生素B群、維生素D及維生素E所成之群的至少一者。
- 如請求項1~7中任一項之組成物,其係醫藥組成物。
- 如請求項1~7中任一項之組成物,其係食品組成物。
- 一種於消化道之吸收的促進用組成物,其含有胱胺酸及麩醯胺之至少一者作為有效成分。
- 如請求項10之組成物,其係於消化道之營養素之吸收的促進用組成物。
- 如請求項11之組成物,其中營養素為選自由蛋白質、胜肽、胺基酸、糖質、脂質、維生素及礦物質所成之群的至少一者。
- 如請求項10~12中任一項之組成物,其係醫藥組成物。
- 如請求項10~12中任一項之組成物,其係食品組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016-209926 | 2016-10-26 | ||
JP2016209926 | 2016-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201829017A true TW201829017A (zh) | 2018-08-16 |
Family
ID=62023500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW106136624A TW201829017A (zh) | 2016-10-26 | 2017-10-25 | 於消化道之吸收降低的改善用組成物、及於消化道之吸收的促進用組成物 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20190247350A1 (zh) |
JP (1) | JPWO2018079573A1 (zh) |
TW (1) | TW201829017A (zh) |
WO (1) | WO2018079573A1 (zh) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0607278T3 (da) * | 1991-10-07 | 2002-06-17 | Brigham & Womens Hospital | Fremgangsmåde til forstærkning af tarmabsorption |
US6221910B1 (en) * | 1999-07-22 | 2001-04-24 | The University Of New Mexico | Glutamine containing oral replacement solution |
US20040156882A1 (en) * | 2002-10-23 | 2004-08-12 | Davenport David F. | Method and composition for feeding mammals |
GB2396809A (en) * | 2003-01-03 | 2004-07-07 | Vitabiotics Ltd | Composition for the treatment of HIV and AIDS |
OA13177A (en) * | 2003-06-04 | 2006-12-13 | Willem Jacob Serfontein | Nutritional compositions and use thereof. |
US8633192B2 (en) * | 2006-12-15 | 2014-01-21 | Tima Foundation | Compositions and uses thereof |
-
2017
- 2017-10-25 JP JP2018547700A patent/JPWO2018079573A1/ja active Pending
- 2017-10-25 WO PCT/JP2017/038423 patent/WO2018079573A1/ja active Application Filing
- 2017-10-25 TW TW106136624A patent/TW201829017A/zh unknown
-
2019
- 2019-04-25 US US16/394,431 patent/US20190247350A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPWO2018079573A1 (ja) | 2019-09-19 |
US20190247350A1 (en) | 2019-08-15 |
WO2018079573A1 (ja) | 2018-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012141316A1 (ja) | 栄養組成物 | |
CN109222103B (zh) | 增肌组合物和保健食品 | |
JP2022064912A (ja) | 哺乳動物において筋タンパク質合成および/または機能強度を増大させる方法および組成物ならびに組成物を製造する方法 | |
JP6551393B2 (ja) | 虚弱予防剤 | |
JP2020531006A (ja) | 筋量および体力を増大させ、肌を処置し、加齢および暴露からの傷みおよび衰えを縮減し、運動および外傷などのストレスからの回復を改善するための組成物および方法 | |
CN111867575B (zh) | 用于改善认知功能的组合物、用于改善焦虑样症状的组合物和用于抑制脑萎缩的组合物 | |
US20190183827A1 (en) | Composition for improving muscular endurance | |
JP6806208B2 (ja) | 消化管障害を改善する組成物 | |
TW201829017A (zh) | 於消化道之吸收降低的改善用組成物、及於消化道之吸收的促進用組成物 | |
WO2017159741A1 (ja) | 行動体力向上剤 | |
US10765663B2 (en) | Nutrition composition | |
US10898456B2 (en) | Ameliorating agent for exercise-induced gastrointestinal disorders | |
WO2021112217A1 (ja) | 肝臓の中性脂肪量の増加抑制用組成物 | |
WO2022244867A1 (ja) | 認知機能の改善用組成物、認知機能改善剤および認知機能の改善用食品 | |
US20200061010A1 (en) | Composition for improving brain function | |
WO2020045612A1 (ja) | 間欠的持久力向上剤または血中pH上昇剤 | |
KR20120039121A (ko) | Nadh를 유효성분으로 하는 근육 피로 회복 또는 근육강화용 조성물 및 그 방법 | |
JP2021087408A (ja) | 腸内デオキシコール酸量低減用組成物 |